Company Profile

Metabolomx (AKA: iSense Medical Corporation)
Profile last edited on: 5/21/2018      CAGE: 5Q1S0      UEI: JK6FZ2TLBLR8

Business Identifier: Sensor technology enabling indicatation of health and fitness from exhaled breath.
Year Founded
2008
First Award
2011
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

500 South Australian Avenue
West Palm Beach, FL 33401
Location: Multiple
Congr. District: 21
County: Palm Beach

Public Profile

Dong business as Metaboomx and also as isense systems, Metabolomx, has developed technology enabling the identification of lung cancer from breath. Metabolomx develops and owns all worldwide rights to the breath test for cancer. It uses CSA technology which is a matrix of colored chemical indicators of diverse reactivities incorporated in a nanoporous sol-gel matrix. It develops breath analysis instrument (BAI) which captures a precise quantity of breath, in a specific portion of the breath cycle and controls the exposure of the colorimetric sensor array(CSA) exam card to the captured breath at a precise flow rate and volume

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 2 NIH $1,149,146
Project Title: Cheap and Fast Ambient Air Monitoring of Pesticides
2012 2 NIH $1,124,636
Project Title: Rapid Breath Detection of Lung Cancer
2011 2 NIH $1,140,000
Project Title: Sensor Array System to Detect Lung Cancer

Key People / Management

  Paul Rhodes -- CEO & Founder

  Sally Larson

  Sung Lim -- Founder

  Ray Martino -- Founder and COO

  Nuria Queralto-Gratacos

  Kenneth Suslick -- Founder